Title : Rapamycin Plus Vildagliptin to Recover β-Cell Function in Long-Standing Type 1 Diabetes: A Double-Blind, Randomized Trial.

Pub. Date : 2021 Jan 23

PMID : 33124663






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rapamycin treatment was associated with a decrease in insulin antibody titer and changes in hormonal/immunological profile. Sirolimus insulin Homo sapiens
2 CONCLUSIONS: Rapamycin reduced insulin requirement, but did not restore beta-cell function in patients with long-standing type 1 diabetes. Sirolimus insulin Homo sapiens